quinacrine has been researched along with Myeloproliferative Disorders in 3 studies
Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.
Myeloproliferative Disorders: Conditions which cause proliferation of hemopoietically active tissue or of tissue which has embryonic hemopoietic potential. They all involve dysregulation of multipotent MYELOID PROGENITOR CELLS, most often caused by a mutation in the JAK2 PROTEIN TYROSINE KINASE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caranobe, C | 1 |
| Sie, P | 1 |
| Nouvel, C | 1 |
| Laurent, G | 1 |
| Pris, J | 1 |
| Boneu, B | 1 |
| Gordon, N | 1 |
| Thom, J | 1 |
| Cole, C | 1 |
| Baker, R | 1 |
| Rendu, F | 1 |
| Lebret, M | 1 |
| Nurden, A | 1 |
| Caen, JP | 1 |
3 other studies available for quinacrine and Myeloproliferative Disorders
| Article | Year |
|---|---|
Platelets in myeloproliferative disorders. II. Serotonin uptake and storage: correlations with mepacrine labelled dense bodies and with platelet density.
Topics: Blood Platelets; Blood Volume; Humans; Myeloproliferative Disorders; Platelet Count; Quinacrine; Ser | 1980 |
Rapid detection of hereditary and acquired platelet storage pool deficiency by flow cytometry.
Topics: Adult; Aged; Aged, 80 and over; Blood Platelet Disorders; Cell Separation; Diagnosis, Differential; | 1995 |
Detection of an acquired platelet storage pool disease in three patients with a myeloproliferative disorder.
Topics: Blood Platelet Disorders; Humans; Myeloproliferative Disorders; Platelet Function Tests; Quinacrine | 1979 |